Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
9,936
Value
$462.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SUPN by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,936$462.1K<0.1%−1,246−11.1%ReducedHolders
Q1 202611,182$578.0K<0.1%−1,882−14.4%ReducedHolders
Q4 202513,064$649.3K<0.1%+866+7.1%AddedHolders
Q3 202512,198$582.9K<0.1%−1,970−13.9%ReducedHolders
Q2 202514,168$446.6K<0.1%−270−1.9%ReducedHolders
Q1 202514,438$472.8K<0.1%−3,401−19.1%ReducedHolders
Q4 202417,839$645.1K<0.1%+4,008+29.0%AddedHolders
Q3 202413,831$431.3K<0.1%−8,321−37.6%ReducedHolders
Q2 202422,152$592.6K<0.1%+8,293+59.8%AddedHolders
Q1 202413,859$472.7K<0.1%+1,021+8.0%AddedHolders
Q4 202312,838$371.5K<0.1%+1,669+14.9%AddedHolders
Q3 202311,169$307.9K<0.1%−170−1.5%ReducedHolders
Q2 202311,339$340.9K<0.1%+277+2.5%AddedHolders
Q1 202311,062$400.8K<0.1%−1,367−11.0%ReducedHolders
Q4 202212,429$443.3K<0.1%+1,068+9.4%AddedHolders
Q3 202211,361$384.0K<0.1%+164+1.5%AddedHolders
Q2 202211,197$323.0K<0.1%−5,370−32.4%ReducedHolders
Q1 202216,567$536.0K<0.1%−3,295−16.6%ReducedHolders
Q4 202119,862$578.0K<0.1%+843+4.4%AddedHolders
Q3 202119,019$507.0K<0.1%−4,694−19.8%ReducedHolders
Q2 202123,713$730.0K<0.1%+1,822+8.3%AddedHolders
Q1 202121,891$573.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.